Aspirin and mortality from coronary bypass surgery

New England Journal of Medicine

Volumn 347, Issue 17, 2002, Pages 1309-1317

  Mangano, Dennis T ^a  

^a Ischemia Research and Education Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLEEDING; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DISEASE ASSOCIATION; FEMALE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; INFECTION; INTESTINE INFARCTION; INTESTINE ISCHEMIA; KIDNEY FAILURE; KIDNEY ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVASCULARIZATION; RISK FACTOR; STROKE; SURGICAL RISK; SURVIVAL; THROMBOCYTE ACTIVATION; TREATMENT PLANNING; WOUND HEALING;

AGED; ANTIFIBRINOLYTIC AGENTS; ASPIRIN; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; PLATELET TRANSFUSION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037167982     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa020798     Document Type: Article

References (41)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-76.
2. Murray CJL, Lopez AD, eds. Global Comparative Assessments in the Health Sector: Disease Burden, Expenditures and Intervention Packages. Geneva: World Health Organization, 1994.
3. Unger F. Cardiac interventions in Europe 1997: Coronary revascularization procedures and open heart surgery. Cor Eur 1999;7:177-89.
4. Loop FD, Irarrazaval MJ, Bredee JJ, Siegel W, Taylor PC, Sheldon WC. Internal mammary artery graft for ischemic heart disease: Effect of revascularization on clinical status and survival. Am J Cardiol 1977;39:516-22.
5. Lichtenstein SV, Ashe KA, el Dalati H, Cusimano RJ, Panos A, Slutsky AS. Warm heart surgery. J Thorac Cardiovasc Surg 1991;101:269-74.
6. Yau TM, Weisel RD, Mickle DA, et al. Alternative techniques of cardioplegia. Circulation 1992;86:Suppl II:II-377-II-384.
7. Julia PL, Buckberg GD, Acar C, Partington MT, Sherman MP. Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: Superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage - Importance of endogenous oxygen free radical scavengers in red blood cells. J Thorac Cardiovasc Surg 1991;101:303-13.
8. Mangano DT. Cardiovascular morbidity, and CABG surgery - A Perspective: epidemiology, costs, and potential therapeutic solutions. J Card Surg 1995;10:Suppl:366-8.
9. Breisblatt WM, Stein KL, Wolfe CJ, et al. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990;15:1261-9.
10. Kloner RA, Przyklenk K, Kay GL. Clinical evidence for stunned myocardium after coronary artery bypass surgery. J Card Surg 1994;9:Suppl:397-402.
11. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996;335:1857-63.
12. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
13. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction following myocardial revascularization: Risk factors, adverse outcomes and hospital resource utilization. Ann Intern Med 1998;128:194-203.
14. Andersen LW, Landow L, Baek L, Jansen E, Baker S. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 1993;21:210-7.
15. Fitzgerald T, Kim D, Karakozis S, Alam H, Provido H, Kirkpatrick J. Visceral ischemia after cardiopulmonary bypass. Am Surg 2000;66:623-6.
16. Herskowitz A, Mangano DT. Inflammatory cascade: A final common pathway for perioperative injury? Anesthesiology 1996;85:957-60.
17. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994;108:626-35.
18. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 1999;79:609-34.
19. Lefer DJ, Shandelya SM, Serrano CV Jr, Becker LC, Kuppusamy P, Zweier JL. Cardioprotective actions ofa monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury. Circulation 1993;88:1779-87.
20. von Asmuth EJ, Buurman WA. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha-induced H202 release by adherent neutrophil leukocytes. J Immunol 1995;154:1383-90.
21. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: Novel effectors of cardioprotection? Circulation 1998;97:2463-9.
22. Théroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988;319:1105-11.
23. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106. [Erratum, BMJ 1994;308:1540.]
24. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86. [Erratum, BMJ 2002;324:141.]
25. Chesebro JH, Fuster V, Elveback LR, et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med 1984;310:209-14.
26. Goldman S, Copeland J, Moritz T, et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: Results of a Veterans Administration cooperative study. Circulation 1988;77:1324-32.
27. Taggart DP, Siddiqui A, Wheatley DJ. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg 1990;50:424-8.
28. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 1999;34:1262-347.
29. Pearson T, Rapaport E, Criqui M, et al. Optimal risk factor management in the patient after coronary revascularization: A statement for health care professionals from an American Heart Association Writing Group. Circulation 1994;90:3125-33.
30. Baumgartner WA, Owens SG, Cameron DE, Reitz BA, eds. The Johns Hopkins Manual of Cardiac Surgical Care. St. Louis: Mosby-Year Book, 1994.
31. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987;2:1289-91.
32. Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993;82:107-17.
33. Khuri SF, Wolfe JA, Josa M, et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992;104:94-107.
34. Morse DS, Adams DH, Magnani B. Platelet and neutrophil activation during cardiac surgical procedures: Impact ofcardiopulmonary bypass. Ann Thorac Surg 1998;65:691-5.
35. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991;75:563-70.
36. Mangano DT, Browner WS, Hollenberg M, et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 1990;323:1781-8.
37. Hessell EA II, Schmer G, Dillard DH. Platelet kinetics during deep hypothermia. J Surg Res 1980;28:23-34.
38. Stover EP, Siegel LC, Parks R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24-institution study. Anesthesiology 1998;88:327-33.
39. Spiess BD, Ley C, Body SC, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1998;116:460-7.
40. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-20. [Erratum, N Engl J Med 1997;336:1039.]
41. Cosgrove DM III, Heric B, Lytle BW, et al. Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study. Ann Thorac Surg 1992;54:1031-6.